Skip to product information
1 of 1

Springer New York

Cancer Epigenetics: Risk Assessment, Diagnosis, Treatment, and Prognosis

Cancer Epigenetics: Risk Assessment, Diagnosis, Treatment, and Prognosis

Regular price $179.00 USD
Regular price Sale price $179.00 USD
Sale Sold out
Shipping calculated at checkout.
Quantity

This volume shares technologies that detect common epigenetic changes which are very important in the early detection, progression, and prognosis of cancer as well as the design of new therapeutic tools against cancer cells.Beginning with a bit of background on epigenetic mechanisms, Cancer Epigenetics: Risk Assessment, Diagnosis, Treatment, and Prognosis continues with cancer specific type epigenetic change, methods and technologies used for detecting epigenetic changes, factors that influence epigenetic changes in cancer, as well as a final section on future directions in the field. Written for the highly successful Methods in Molecular Biology series, chapters in this volume include the kind of detailed implementation advice that guarantees easily reproducible results.

Comprehensive and practical, Cancer Epigenetics: Risk Assessment, Diagnosis, Treatment, and Prognosis provides the most up-to-date knowledge of epigenetics and its implication in cancer prevention by risk assessment and screening and cancer control by treatment.

View full details